The pharmacokinetics of azithromycin and their clinical significance.
about
Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutionsInsights into the pharmacokinetic properties of antitubercular drugs.Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).Intravenous azithromycin.The new macrolides. Azithromycin and clarithromycin.Intracellular activity of azithromycin against bacterial enteric pathogens.In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydiaInvasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review.Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye.Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral dosesEnrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection.In vitro activities of new macrolides and rifapentine against Brucella spp.Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers.Pharmacokinetics of EDP-420 after multiple oral doses in healthy adult volunteers and in a bioequivalence study.Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.Preparation, characterization and taste-masking properties of microspheres containing azithromycin.Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children.Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers.Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days.
P2860
Q26996622-75660D0F-D9A4-4A2A-AB96-7E0F3FDE3E58Q30251497-5A37D5FB-D085-455B-8E4D-E3FBCA5C3746Q30662421-5E5C1BD3-0838-4F6F-9A46-E180D512BF81Q33543121-C5D4F7A1-8231-46BE-845A-5B7951DF5F86Q33607251-51AFD44B-0AA5-46A1-A374-3870353C5D17Q33757644-C33350F9-61F7-40D6-8B83-356F7678D3A5Q33760662-FFE19268-396A-48C6-9499-7749A3B191B7Q35096801-220F4946-9973-4E63-90BD-7A62047CD02AQ35123496-C628B8F8-FE7D-4E51-B92C-E6AF2217856DQ35129323-8BCEBE67-4125-48F2-A799-1B7B0C29F6D5Q35175244-DA9C129D-3819-4E51-8BCD-A995126F9BA4Q35812997-2DC633E4-3FE7-4E64-BD90-1D659CDED8ADQ37190854-68B7A862-9400-4EF4-B181-D0034B9F9E1BQ37274742-D9C77DEE-1D90-44A6-93CA-18E0E9C2834CQ40088846-92409DD5-B920-4A27-AFCA-B24E6F72B687Q43230731-2287C051-E939-447E-9600-1AC756092E41Q45027018-BB1EEC29-9D13-4ADF-B5D3-FFB1EA363C03Q46459998-377590C2-C125-42DC-A44B-72965D1B5C1BQ46699473-6730DBFD-B784-4437-BDA5-9DBB04C554DB
P2860
The pharmacokinetics of azithromycin and their clinical significance.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
The pharmacokinetics of azithromycin and their clinical significance.
@ast
The pharmacokinetics of azithromycin and their clinical significance.
@en
type
label
The pharmacokinetics of azithromycin and their clinical significance.
@ast
The pharmacokinetics of azithromycin and their clinical significance.
@en
prefLabel
The pharmacokinetics of azithromycin and their clinical significance.
@ast
The pharmacokinetics of azithromycin and their clinical significance.
@en
P2860
P356
P1476
The pharmacokinetics of azithromycin and their clinical significance.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF01975832
P577
1991-10-01T00:00:00Z